Have a feature idea you'd love to see implemented?
Let us know!
ENSC Ensysce Biosciences Inc
Price (delayed)
$0.5924
Market cap
$11.6M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.07
Enterprise value
$7.83M
Highlights
ENSC's quick ratio has soared by 175% YoY and by 119% from the previous quarter
ENSC's net income is up by 37% year-on-year and by 30% since the previous quarter
Ensysce Biosciences's debt has decreased by 15% from the previous quarter but it has increased by 9% YoY
Key stats
What are the main financial stats of ENSC
Market
Valuations
Earnings
Shares outstanding
19.57M
Market cap
$11.6M
Enterprise value
$7.83M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.73
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$6.3M
EBITDA
-$6.3M
Free cash flow
-$8.54M
Per share
Balance sheet
Liquidity
EPS
-$2.07
Free cash flow per share
-$0.86
Book value per share
$0.82
Revenue per share
$0
TBVPS
$0.95
Total assets
$9.38M
Total liabilities
$2.8M
Debt
$387,176
Equity
$6.91M
Working capital
$6.29M
Debt to equity
0.06
Current ratio
3.24
Quick ratio
2.12
Net debt/EBITDA
0.6
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-158.8%
Return on equity
-261.1%
Return on invested capital
-812.4%
Return on capital employed
-95.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ENSC stock price
How has the Ensysce Biosciences stock price performed over time
Intraday
-9.65%
1 week
-6.81%
1 month
187.57%
1 year
-31.12%
YTD
-44.11%
QTD
146.83%
Financial performance
How have Ensysce Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.31M
Net income
-$7.93M
Gross margin
N/A
Net margin
N/A
Ensysce Biosciences's operating income has surged by 54% YoY and by 35% QoQ
ENSC's net income is up by 37% year-on-year and by 30% since the previous quarter
Growth
What is Ensysce Biosciences's growth rate over time
Valuation
What is Ensysce Biosciences stock price valuation
P/E
N/A
P/B
0.73
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 31% QoQ and by 16% YoY
Efficiency
How efficient is Ensysce Biosciences business performance
Ensysce Biosciences's return on invested capital has surged by 92% QoQ
ENSC's return on equity has surged by 89% year-on-year and by 61% since the previous quarter
The company's return on assets has surged by 51% QoQ and by 39% YoY
Dividends
What is ENSC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ENSC.
Financial health
How did Ensysce Biosciences financials performed over time
Ensysce Biosciences's total assets has surged by 192% YoY
ENSC's quick ratio has soared by 175% YoY and by 119% from the previous quarter
Ensysce Biosciences's debt is 94% less than its equity
ENSC's debt to equity has shrunk by 76% QoQ and by 75% YoY
Ensysce Biosciences's debt has decreased by 15% from the previous quarter but it has increased by 9% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.